Phase II trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Phase II trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer.
Authors: Young, S. D.1 syoung@hrsrh.on.ca, Lafrenie, R. M.2, Clemons, M. J.3
Source: Current Oncology. Apr2012, Vol. 19 Issue 2, pe75-e83. 9p.
Database: Academic Search Ultimate
Description
ISSN:11980052
DOI:10.3747/co.19.879